PDLIM1通过激活Hippo信号抑制肝细胞癌转移
本研究探讨PDLIM1在肝细胞癌(HCC)转移中的作用机制。发现PDLIM1在转移性HCC组织中显著下调且预示不良预后;功能实验表明PDLIM1敲低促进上皮间质转化、侵袭和转移,过表达则相反。机制上PDLIM1竞争性结合ACTN4,阻止F-actin过度生长,从而调控Hippo信号抑制转移。
要点
- PDLIM1在转移性HCC中下调,预示不良预后。
- PDLIM1敲低促进HCC细胞EMT、侵袭和转移。
- PDLIM1通过结合ACTN4调控Hippo信号抑制转移。
核心结论
- PDLIM1通过调节Hippo信号抑制HCC转移,可能作为转移性HCC的预后标志物。
研究设计与样本
- 研究采用功能实验(敲低和过表达PDLIM1)在体外和体内评估对HCC细胞EMT、侵袭和转移的影响,并探讨分子机制。
主要发现
- PDLIM1在转移性人HCC组织中显著下调,预测不良预后。
- PDLIM1敲低诱导HCC细胞EMT,提高侵袭能力,并在体外和体内促进转移;过表达则相反。
- PDLIM1竞争性结合ACTN4,导致ACTN4与F-actin解离,防止F-actin过度生长;PDLIM1缺失导致F-actin过度形成,引起LATS1去磷酸化和YAP激活,促进HCC转移。
- PDLIM1的Asn145(N145)对其与ACTN4的相互作用至关重要,N145A突变消除其对Hippo信号和HCC转移的调节功能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Tumor metastasis is a major factor of high recurrence and mortality in hepatocellular carcinoma (HCC), but its underlying mechanism remains elusive. We report that PDZ and LIM domain protein 1 (PDLIM1) is significantly down-regulated in metastatic human HCC tissues, which predicts unfavorable prognosis, suggesting that PDLIM1 may play an important inhibitory role during HCC metastasis. APPROACH AND RESULTS: Functional studies indicate that PDLIM1 knockdown induces epithelial-to-mesenchymal transition (EMT) of HCC cells, elevates their invasive capacity, and promotes metastasis in vitro and in vivo, whereas overexpression of PDLIM1 exhibits opposite phenotypes. Mechanistically, PDLIM1 competitively binds to the cytoskeleton cross-linking protein alpha-actinin 4 (ACTN4), leading to the disassociation of ACTN4 from F-actin, thus preventing F-actin overgrowth. In contrast, loss of PDLIM1 induces excessive F-actin formation, resulting in dephosphorylation of large tumor suppressor kinase 1 and activation of Yes-associated protein, thereby promoting HCC metastasis. Moreover, Asn145 (N145) of PDLIM1 is critical for its interaction with ACTN4, and N145A mutation abolishes its regulatory function in Hippo signaling and HCC metastasis. CONCLUSIONS: Our findings indicate that PDLIM1 suppresses HCC metastasis by modulating Hippo signaling, suggesting that PDLIM1 may be a potential prognostic marker for metastatic HCC.
引用
- Huang Z, Zhou JK, Wang K, et al. PDLIM1 Inhibits Tumor Metastasis Through Activating Hippo Signaling in Hepatocellular Carcinoma. Hepatology. 2020. PMID: 31509262. doi:10.1002/hep.30930
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。